We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Breast cancer type 2 susceptibility protein antibody
Breast cancer type 2 susceptibility protein
Fanconi anemia group D1 protein
Gene name: BRCA2, FACD, FANCD1
Fanconi anemia group D1 protein
Gene name: BRCA2, FACD, FANCD1
As low as
$306.10
In stock
Ref
00013874
Breast cancer type 2 susceptibility protein antibody
| ID Covalab | pab0457 |
|---|---|
| Product type | Primary antibodies |
| Clonality | Polyclonal antibody |
| Raised in | Rabbit |
| Immunogen | Synthetic peptide derived from Nter domain of human BRCA2 |
| Activity cross reaction | Reacts with human 384 kDa BRCA2 protein. Cross reacts with phospho-Ser 28 BRCA2. May cross react with proteins from mouse, rat and other species due to sequence homology. |
| Species | Hu |
| Labelling | None |
| Form | Antiserum |
| Preservative | None |
| Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | Breast cancer type 2 susceptibility protein |
| Uniprot ID | P51587 |
| Gene ID | 675 |
| Applications | ELISA, IHC - P, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : IHC-P (1:50 - 1:500) WB (1:200 - 1:2000) |
| Publication | * Balacescu O et al. BMC Cancer. 2014 Apr 8,14:246. (IHC, Hu) |
Write Your Own Review